Psychometric Evaluation Of The Psoriasis Symptom Diary Using Phase 3 Trial Data
Bruce Strober(Yale University), Mark Lebwohl(Icahn School of Medicine at Mount Sinai), Lori McLeod(RTI International), Margaret Mordin(RTI Health Solutions), Alice B. Gottlieb(The University of Texas Southwestern Medical Center), Yaling Zhao(Novartis (United States)), Lauren Nelson(RTI Health Solutions), Ari Gnanasakthy(RTI Health Solutions), MH Tran(Novartis (United States)), BE Elewski(University of Alabama at Birmingham)
Cited by 1
Related Papers
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
|Journal of the American Academy of Dermatology|2019|917
Psoriasis
|Nature Reviews Disease Primers|2016|893
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
|Quality of Life Research|2013|855
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
|Journal of the American Academy of Dermatology|2019|484
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
|New England Journal of Medicine|2008|388